Craft

Fisher & Paykel Healthcare

Stock Price

$35.6

2024-08-30

Market Capitalization

$20.9 B

2024-08-30

Revenue

$1.7 B

FY, 2024

Fisher & Paykel Healthcare Summary

Company Summary

Overview
Fisher & Paykel Healthcare is a company that designs, manufactures, and markets products for use in respiratory care, acute care, and the treatment of obstructive sleep apnea. It offers respiratory humidifiers, single-use and reusable chambers and breathing circuits, infant resuscitators, infant warmers, and accessories. In addition, the company provides humidification systems for use in surgical procedures to condition dry carbon dioxide gas to normal physiological levels of temperature and humidity.
Type
Public
Status
Active
Founded
1971
HQ
Auckland, NZ | view all locations
Website
https://www.fphcare.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Lewis Gradon

    Lewis Gradon, Managing Director & Chief Executive Officer

    • Andrew Somervell

      Andrew Somervell, Vice President – Products & Technology

      • Winston Fong

        Winston Fong, Vice President – Surgical Technologies

        LocationsView all

        29 locations detected

        • Auckland, Auckland HQ

          New Zealand

          15 Maurice Paykel Place, East Tāmaki, PO Box 14 348

        • Irvine, CA

          United States

          17400 Laguna Canyon Rd #300

        • Melbourne, VIC

          Australia

          19-31 King Street

        • Wien, Wien

          Austria

          Wagramer Str. 19/13. Stock

        • Sao Paulo, SP

          Brazil

          277 Sampaio Viana 2nd Floor, Offices 21 and 22

        • Laval, QC

          Canada

          2045 Bd Dagenais O #180

        and 23 others

        Fisher & Paykel Healthcare Financials

        Summary Financials

        Revenue (H1, 2025)
        $951.2M
        Gross profit (H1, 2025)
        $656.1M
        Net income (H1, 2025)
        $153.2M
        Cash (H1, 2025)
        $116.6M
        EBIT (H1, 2025)
        $218.1M
        Enterprise value
        $20.8B

        Footer menu